MDLinx touts its MRA Verified panel

Share this article:

MDLinx, a division of M3 USA, had its physician panel verified by the Marketing Research Association (MRA), a process that involved a review of MDLinx's survey methodology, sample size and other procedural rules.

Craig Overpeck, chief technology officer at MDLinx, said the company's international panel of doctors—which includes 660,000 physicians across 24 specialties —was deemed “MRA Verified” after providing MRA with a self-assessment, and allowing the association to conduct an independent review. MDLinx provides medical news to doctors via emails, and, beginning three years ago, surveys doctors that receive the emails or sign up to participate in market research as panel member.

Physicians participate in a given survey for an MDLinx client by invitation, and use an invitation code to respond to survey questions.

Overpeck says the company's panel includes “one of every two oncologists in the US,” and approximately 130,000 US docs in total.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?